Genfit SA (GNFT)
4.20
-0.04
(-0.94%)
USD |
NASDAQ |
Nov 22, 16:00
4.21
+0.01
(+0.24%)
After-Hours: 20:00
Genfit Revenue (TTM): 30.01M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 30.01M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
30.01M
Minimum
Dec 2023
30.01M
Maximum
Dec 2023
30.01M
Average
30.01M
Median
Dec 2023
Revenue (TTM) Benchmarks
| Edap TMS SA | 68.72M |
| DBV Technologies SA | -- |
| Cellectis SA | 29.07M |
| Adaptimmune Therapeutics PLC | 175.04M |
| Akari Therapeutics PLC | -- |